{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:08:47Z","timestamp":1747109327145,"version":"3.40.5"},"reference-count":31,"publisher":"Georg Thieme Verlag KG","issue":"CP","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endosc Int Open"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pancreatic metastases from renal cell carcinoma (RCC) are usually managed surgically but with significant morbidity. As an alternative, endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) has shown promising results in treatment of pancreatic neuroendocrine tumors. The aim of our study was to assess technical success, effectiveness, and safety of EUS-RFA in patients with pancreatic metastases of RCC.<\/jats:p><jats:p>This retrospective, observational study included consecutive patients referred for EUS-RFA of pancreatic RCC metastases. EUS-RFA was performed through 18G or 19G dedicated RFA needles. Effectiveness of EUS-RFA treatment was defined by necrosis with no contrast enhancement or lesion disappearance, determined by contrast-enhanced computed tomography (CT) scan, at 2 to 5 months post procedure, 1 year, and at the end of follow-up. Safety was assessed per and post procedure.<\/jats:p><jats:p>Between January 2015 and January 2021, eight patients with 11 lesions were treated and median time from RCC diagnosis to pancreatic metastases RFA was 8.5 years (1\u201315). Mean lesion size was 13.9 mm (\u00b1 3.9). Technical success assessed by immediate post procedure contrast-enhanced CT or Doppler was 100%. At the first CT scan follow-up, complete response was 45.4% and partial response was 27.3%. At 1 year, complete response was 45.4% and partial response was 27.3%. Three patients had multiple EUS-RFAs. Adverse events occurred in 3 patients (mild acute pancreatitis, abdominal pain, and pancreatic fistula with retro-gastric pseudocyst).<\/jats:p><jats:p>Our study demonstrated the feasibility and safety of EUS-RFA for patients with pancreatic metastases of RCC.<\/jats:p>","DOI":"10.1055\/a-2566-7350","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T02:40:00Z","timestamp":1742956800000},"source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Effectiveness and safety of endoscopic ultrasound-guided radiofrequency ablation for pancreatic metastases of renal cell carcinoma."],"prefix":"10.1055","volume":"13","author":[{"given":"Morgane","family":"Stouvenot","sequence":"additional","affiliation":[{"name":"Gastroenterology, Centre Hospitalier R\u00e9gional Universitaire de Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Koch","sequence":"additional","affiliation":[{"name":"Gastroenterology, Centre Hospitalier R\u00e9gional Universitaire de Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Frontzcak","sequence":"additional","affiliation":[{"name":"Urology, Centre Hospitalier R\u00e9gional Universitaire de Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"D'Engremont","sequence":"additional","affiliation":[{"name":"CHU Grenoble Alpes, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Boinette","sequence":"additional","affiliation":[{"name":"Gastroenterology, Centre Hospitalier R\u00e9gional Universitaire de Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Doussot","sequence":"additional","affiliation":[{"name":"Digestive Surgery, Centre Hospitalier R\u00e9gional Universitaire de Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan","family":"Maurina","sequence":"additional","affiliation":[{"name":"Oncology, Centre Hospitalier R\u00e9gional Universitaire de Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucine","family":"Vuitton","sequence":"additional","affiliation":[{"name":"Gastroenterology, Centre Hospitalier R\u00e9gional Universitaire de Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"RL Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"ref2","first-page":"1","article-title":"Current management of advanced and metastatic renal cell carcinoma","volume":"7","author":"MH Ather","year":"2010","journal-title":"Urol J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.3748\/wjg.v17.i43.4747","article-title":"Pancreatic metastases from renal cell carcinoma: The state of the art","volume":"17","author":"R Ballarin","year":"2011","journal-title":"World J Gastroenterol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00268-021-06071-x","article-title":"How should we treat pancreatic metastases from renal cell carcinoma? A meta-analysis","volume":"45","author":"T Hirashita","year":"2021","journal-title":"World J Surg"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1245\/ASO.2006.03.064","article-title":"Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: An indication for pancreatic surgery","volume":"13","author":"F Sellner","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/cncr.25836","article-title":"Survival after complete surgical resection of multiple metastases from renal cell carcinoma","volume":"117","author":"AL Alt","year":"2011","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.4065\/75.6.581","article-title":"Renal cell carcinoma metastatic to the pancreas: Clinical and radiological features","volume":"75","author":"R Ghavamian","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/bjs.4072","article-title":"High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma","volume":"90","author":"C Bassi","year":"2003","journal-title":"Br J Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/s0399-8320(04)95151-2","article-title":"Pancreatic metastases: a multicentric study of 22 patients","volume":"28","author":"A Moussa","year":"2004","journal-title":"Gastroent\u00e9rologie Clin Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1245\/s10434-007-9782-0","article-title":"Pancreatic metastasis from renal cell carcinoma: Which patients benefit from surgical resection?","volume":"15","author":"A Zerbi","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1007\/s00268-014-2672-2","article-title":"Pancreatic secondary lesions from renal cell carcinoma","volume":"38","author":"L Moletta","year":"2014","journal-title":"World J Surg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/2319-4170.137771","article-title":"The role of surgery in renal cell carcinoma with pancreatic metastasis","volume":"38","author":"C-C Liaw","year":"2015","journal-title":"Biomed J"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151662","article-title":"Clinical impact of pancreatic metastases from renal cell carcinoma: A multicenter retrospective analysis","volume":"11","author":"P Grassi","year":"2016","journal-title":"PLOS ONE"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.hpb.2019.10.017","article-title":"Pancreatic resection for metastatic renal cell carcinoma. A systematic review","volume":"22","author":"I Jaen-Torrejimeno","year":"2019","journal-title":"HPB (Oxford)"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejso.2021.08.011","article-title":"Pancreatic metastases from renal cell carcinoma. Postoperative outcome after surgical treatment in a Spanish multicenter study (PANMEKID)","volume":"48","author":"G Blanco-Fern\u00e1ndez","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1055\/a-0824-7067","article-title":"Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study","volume":"51","author":"M Barthet","year":"2019","journal-title":"Endoscopy"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.15403\/jgld.2014.1121.271.eus","article-title":"EUS-guided Radiofrequency ablation (EUS-RFA) of solid pancreatic neoplasm using an 18-gauge needle electrode: Feasibility, safety, and technical success","volume":"27","author":"SF Crin\u00f2","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"E1754","DOI":"10.1055\/a-1261-9359","article-title":"Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series","volume":"08","author":"G de Nucci","year":"2020","journal-title":"Endosc Int Open"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/MEG.0000000000002422","article-title":"Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors","volume":"7","author":"M Pai","year":"2015","journal-title":"World J Gastrointest Surg"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"E1178","DOI":"10.1055\/a-1479-2199","article-title":"Long-term outcome after EUS-guided radiofrequency ablation: Prospective results in pancreatic neuroendocrine tumors and pancreatic cystic neoplasms","volume":"09","author":"M Barthet","year":"2021","journal-title":"Endosc Int Open"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"EA Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.3390\/cancers13215267","article-title":"Endoscopic ultrasound-guided radiofrequency ablation as an future alternative to pancreatectomy for pancreatic metastases from renal cell carcinoma: A prospective study","volume":"13","author":"B Chanez","year":"2021","journal-title":"Cancers"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.gie.2023.04.003","article-title":"Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study)","volume":"98","author":"B Napol\u00e9on","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.pan.2021.07.001","article-title":"Differentiation between pancreatic metastases from renal cell carcinoma and pancreatic neuroendocrine neoplasm using endoscopic ultrasound","volume":"21","author":"K Kataoka","year":"2021","journal-title":"Pancreatology"},{"key":"ref25","first-page":"R5","article-title":"Recommandations fran\u00e7aises du Comit\u00e9 de Canc\u00e9rologie de l\u2019AFU - Actualisation 2018\u20132020 : prise en charge du cancer du rein French ccAFU guidelines - Update 2018--2020: Management of kidney cancer","volume":"28","author":"K Bensalah","year":"2018","journal-title":"Progr\u00e8s En Urol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"BI Rini","year":"2019","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S1470-2045(19)30413-9","article-title":"Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial","volume":"20","author":"RJ Motzer","year":"2019","journal-title":"Lancet Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1158\/0008-5472.CAN-03-3949","article-title":"In situ tumor ablation creates an antigen source for the generation of antitumor immunity","volume":"64","author":"MHMGM den Brok","year":"2004","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/02656736.2021.1991011","article-title":"Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis","volume":"38","author":"X Wang","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.792781","article-title":"Combination of ablation and immunotherapy for hepatocellular carcinoma: Where we are and where to go","volume":"12","author":"K Wang","year":"2021","journal-title":"Front Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1158\/1078-0432.CCR-15-1352","article-title":"PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor","volume":"22","author":"L Shi","year":"2016","journal-title":"Clin Cancer Res"}],"container-title":["Endoscopy International Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2566-7350.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:02:35Z","timestamp":1747094555000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2566-7350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":31,"journal-issue":{"issue":"CP","published-online":{"date-parts":[[2025,1,7]]},"published-print":{"date-parts":[[2025]]}},"alternative-id":["a25667350"],"URL":"https:\/\/doi.org\/10.1055\/a-2566-7350","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2364-3722","2196-9736"],"issn-type":[{"type":"print","value":"2364-3722"},{"type":"electronic","value":"2196-9736"}],"subject":[],"published-other":{"date-parts":[[2025,3,25]]},"published":{"date-parts":[[2025,3,25]]}}}